Form 4 for UTHR UNITED THERAPEUTICS Corp
Accepted 2026-01-05 00:00:00 ET · period of report 2026-01-02 · accession 0001237334-26-000001 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DT | 2026-01-05 | 2026-01-02 | UTHR | CAUSEY CHRISTOPHER | Dir | S - Sale+OE | $500.01 | -1,000 | 4,190 | -19% | -$500.0K |
| DT | 2026-01-05 | 2026-01-02 | UTHR | CAUSEY CHRISTOPHER | Dir | M - OptEx | $119.76 | +1,000 | 5,190 | +24% | +$119.8K |
| DT | 2026-01-05 | 2026-01-02 | UTHR | CAUSEY CHRISTOPHER | Dir | M - OptEx | $0.00 | -1,000 | 8,320 | -11% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-01-02 | S | D | 1,000 | $500.01 | 4,190 | D | — | — | (F2) This transaction was executed in multiple trades at prices ranging from $500.00 to $500.21. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
| 2 | Common | Common Stock | 2026-01-02 | M | A | 1,000 | $119.76 | 5,190 | D | — | — | |
| 3 | Derivative | Stock Option | 2026-01-02 | M | D | 1,000 | $0.00 | 8,320 | D | $119.76 · 2021-06-26 to 2030-06-26 | 1,000 Common Stock |